Chronic viral hepatitis in children: Any role for the pathologist?

Gut

Volumn 57, Issue 7, 2008, Pages 873-877

  Guido, Maria ^a,b   Bortolotti, Flavia ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b Istituto di Anatomia Patologica   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; HEPATITIS B CORE ANTIGEN; HEPATITIS B(E) ANTIGEN; INTERFERON; LAMIVUDINE; RIBAVIRIN; VIRUS DNA; VIRUS RNA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIGEN EXPRESSION; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHRONIC HEPATITIS; CLINICAL EXAMINATION; DELTA AGENT HEPATITIS; DIAGNOSTIC VALUE; DISEASE COURSE; HEPATITIS B; HEPATITIS C; HISTOPATHOLOGY; HUMAN; LIVER BIOPSY; PRIORITY JOURNAL; REVIEW; TREATMENT INDICATION; VIRUS LOAD;

ANTIVIRAL AGENTS; BIOPSY; CHILD; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; LIVER; PHYSICIAN'S ROLE;

EID: 46349100098     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2007.139410     Document Type: Review

References (77)

1. Williams R. Global challenges in liver disease. Hepatology 2006;44:521-6.
2. Alter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999;41:556-62.
3. Romanò L, Azara A, Chiaramonte M, et al. Low prevalence of anti-HCV antibody among Italian children. Infection 1994;22:350-2.
4. Resti M, Azzari C, Galli L, et al. Italian Study Group on Mother-to-Infant Hepatitis C Virus transmission. Maternal drug use is a preeminent risk factor for mother-to-child hepatitis C virus transmission: results from a multicenter study of 1372 mother-infant pairs. J Infect Dis 2002;185:567-72.
5. Jhaveri R, Grant W, Kauf TL, et al. The burden of hepatitis C virus infection in children: estimated direct medical costs over a 10-year period. J Pediatr 2006;148:353-8.
6. Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med 2001;344:495-500.
7. Rockey DC, Bissell DM. Non-invasive measures of liver fibrosis. Hepatology 2006;43:S113-20.
8. Rosenberg WM, Voelker M, Thiel R, et al. Serum markers detect the presence of liver fibrosis: a cohort study. Gastroenterology 2004;127:1704-13.
9. Castera L, Vergniol J, Foucher J, et al. Prospective comparison of transient elastography, Fibrotest, APRI and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005;128:343-50.
10. Sebastiani G, Vario A, Guido M, et al. Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C. J Hepatol 2006;44:686-93.
11. Guido M, Rugge M. Liver biopsy sampling in chronic viral hepatitis. Semin Liver Dis 2004;24:89-97.
12. Guido M, Colloredo G, Fassan M, et al. Clinical practice and ideal liver biopsy sampling standards: not just a matter of centimetres. J Hepatol 2006;44:818-26.
13. Colloredo G, Guido M, Sonzogni A, et al. Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. J Hepatol 2003;39:239-44.
14. Bedossa P, Dargère D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003;38:1449-57.
15. Brunetti E, Silini E, Pistorio A, et al. Coarse vs. fine needle aspiration biopsy for the assessment of diffuse liver disease from hepatitis C virus-related chronic hepatitis. J Hepatol 2004;40:501-6.
16. Chang MH. Natural history of hepatitis B virus infection in children. J Gastroenterol Hepatol 2000;15:S1619.
17. Lok AS, Lai CL. A longitudinal follow-up of asymptomatic hepatitis B surface antigen-positive Chinese children. Hepatology 1988;8:1130-3.
18. Chu CM, Liaw YF. Natural history differences in perinatally versus adult-acquired diseases. Curr Hepat Rep 2004;3:123-31.
19. Bortolotti F. Chronic hepatitis B in childhood: unanswered questions and evolving issues. J Hepatol 1994;21:904-9.
20. Bortolotti F, Guido M, Bartolacci S, et al. Chronic hepatitis B in children after e antigen seroclearance: final report of a 29-year longitudinal study. Hepatology 2006;43:556-62.
21. Bortolotti F, Crivellaro C, Brunetto MR, et al. Selection of a precore mutant of hepatitis B virus and reactivation of chronic hepatitis B acquired in childhood. J Pediatr 1993;123:583-5.
22. Bortolotti F. Treatment of chronic hepatitis B in children. J Hepatol 2003;39:S200-5.
23. Broderick A, Jonas MM. Management of hepatitis B in children. Clin Liver Dis 2004;8:387-401.
24. Shneider BL, Gonzalez-Peralta R, Roberts EA. Controversies in the management of pediatric liver disease: hepatitis B, C and NAFLD. Summary of a single topic conference. Hepatology 2006;44:1344-54.
25. D'Antiga L, Aw M, Atkins M, et al. Combined lamivudine/interferon-alpha treatment in "immunotolerant" children perinatally infected with hepatitis B: a pilot study. J Pediatr 2006;148:228-33.
26. Suriawinata AA, Thung SN. Acute and chronic hepatitis. Semin Diagn Pathol 2006;23:132-48.
27. Hsu HC, Lin YH, Chang MH, et al. Pathology of chronic hepatitis B virus infection in children: with special reference to the intrahepatic expression of hepatitis B virus antigens. Hepatology 1988;8:378-82.
28. Chang MH, Hwang LY, Hsu HC, et al. Prospective study of asymptomatic HBsAg carrier children infected in the perinatal period: clinical and liver histologic studies. Hepatology 1988;8:37477.
29. Bortolotti F, Calzia R, Vegnente A, et al. Chronic hepatitis in childhood: the spectrum of the disease. Gut 1988;29:659-64.
30. Thiese N. Liver biopsy assessment in chronic viral hepatitis: a personal, practical approach. Mod Pathol 2007;20:S3-14.
31. Hsu HC, Lai My, Su IJ, et al. Correlation of hepatocyte HBsAg expression with virus replication and liver pathology. Hepatology 1988;8:749-54.
32. Hsu HC, Su IJ, Lai MY, et al. Biologic and prognostic significance of hepatocyte hepatitis B core antigen expression in the natural course of chronic hepatitis B virus infection. J Hepatol 1987;5:45-50.
33. Guido M, Thung SN, Fattovich G, et al. Intrahepatic expression of hepatitis B virus antigens: effect of hepatitis C virus infection. Mod Pathol 1999;12:599-603.
34. Soderstrom A, Norkrans G, Conradi N, et al. Histologic activity of childhood chronic hepatitis B related to viremia levels, genotypes, mutations, and epidemiologic factors. J Pediatr Gastroenterol Nutr 2002;35:487-94.
35. Rugge M, Guido M, Bortolotti F, et al. Histology and virus expression in the liver: a prognostic puzzle in chronic hepatitis B. Virchows Arch 1991;419:93-7.
36. Bortolotti F, Cadrobbi P, Crivellaro C, et al. Long-term outcome of chronic type B hepatitis in patients who acquire hepatitis B virus infection in childhood. Gastroenterology 1990;99:805-10.
37. Ruiz-Moreno M, Otero M, Millan A, et al. Clinical and histological outcome after hepatitis B e antigen to antibody seroconversion in children with chronic hepatitis B. Hepatology 1999;29:572-5.
38. Bortolotti F, Guido M, Cadrobbi P, et al. Spontaneous regression of hepatitis B virus-associated cirrhosis developed in childhood. Dig Liver Dis 2005;37:964-7.
39. Ruiz-Moreno M, Camps T, Jimenes J, et al. V. Factors predictive of response to interferon therapy in children with chronic hepatitis B. J Hepatol 1995;22:540-4.
40. Jonas MM, Kelly DA, Mizerski J, et al. Clinical trial of lamivudine in children with chronic hepatitis B. N Engl J Med 2002;346:1706-13.
41. Hom X, Little N, Gardner S, et al. Predictors of virologie response to lamivudine treatment in children with chronic hepatitis B infection. Pediatr Infect Dis 2004;23:441-5.
42. Wisell J, Boitnott J, Haas M, et al. Glycogen pseudoground glass change in hepatocytes. Am J Surg Pathol 2006;30:1085-90.
43. Lefkowitch JH, Lobritto SJ, Brown RS Jr, et al. Ground-glass, polyglucosan-like hepatocellular inclusions: a "new" diagnostic entity. Gastroenterology 2006;131:713-8.
44. Jara P, Bortolotti F. Interferon-alpha treatment of chronic hepatitis B in childhood: a consensus advice based on experience in European children. J Pediatr Gastroenterol Nutr 1999;29:163-70.
45. Jonas MM. Children with hepatitis C. Hepatology 2002;36:S173-8.
46. Bortolotti F, Resti M, Marcellini M, et al. Hepatitis C virus (HCV) genotypes in 373 Italian children with HCV infection: changing distribution and correlation with clinical features and outcome. Gut 2005;54:852-7.
47. Bortolotti F, Jorio R, Resti M, et al. Italian Observatory for HCV Infection and Hepatitis C in Children. Epidemiological profile of 806 Italian children with hepatitis C virus infection over a 15-year period. J Hepatol 2007;46:783-90.
48. Resti M, Jara P, Hierro L, et al. Clinical features and progression of perinatally acquired hepatitis C virus infection. J Med Virol 2003;70:373-7.
49. Jara P, Resti M, Hierro L, et al. Chronic hepatitis C virus infection in childhood: clinical patterns and evolution in 224 white children. Clin Infect Dis 2003;36:275-80.
50. Zuccotti GV, Salvini F, Farina F, et al. Longitudinal long-term follow-up study of children with vertically acquired hepatitis C virus infection. J Int Med Res 2006;34:215-22.
51. Gerotto M, Resti M, Dal Pero F, et al. Evolution of hepatitis C virus quasispecies in children with chronic hepatitis C. Infection 2006;34:62-5.
52. Casiraghi MA, De Paschale M, Romano L, et al. Long-term outcome (35 years) of hepatitis C after acquisition of infection through mini transfusions of blood given at birth. Hepatology 2004;39:90-6.
53. Posthouwer D, Fischer K, van Erpecum KJ, et al. The natural history of childhood-acquired hepatitis C infection in patients with inherited bleeding disorders. Transfusion 2006;46:1360-6.
54. Narkewicz MR, Cabrera R, Gonzalez-Peralta RP. The "c" of viral hepatitis in children. Semin Liver Dis 2007;27:295-311.
55. Bortolotti F, Iorio R, Nebbia G, et al. Interferon treatment in children with chronic hepatitis C: Long-lasting remission in responders, and risk for disease progression in non-responders. Dig Liv Dis 2005;37:336-41.
56. Gonzalez-Peralta RP, Kelly DA, Haber B, et al. Interferon alpha-2b in combination with ribavirin for the treatment of chronic hepatitis C in children: efficacy, safety, and pharmacokinetics. Hepatology 2005;42:1010-8.
57. Kowala-Piaskowska A, Sluzewski W, Figlerowicz M, et al. Early virological response in children with chronic hepatitis C treated with pegylated interferon and ribavirin. Infection 2007;35:175-9.
58. Guido M, Rugge M, Jara P, et al. Chronic hepatitis C in children: the pathological and clinical spectrum. Gastroenterology 1998;115:1525-9.
59. Kage M, Fujisawa T, Shiraki K, et al. Pathology of chronic hepatitis C in children. Hepatology 1997;26:771-5.
60. Badizadegan K, Jonas MM, Ott MJ, et al. Histopathology of the liver in children with chronic hepatitis C viral infection. Hepatology 1998;28:1416-23.
61. Fujisawa T, Inui A, Komatsu H, et al. A comparative study on pathologic features of chronic hepatitis C and B in pediatric patients. Pediatr Pathol Mol Med 2000;9:469-80.
62. Mohan P, Colvin C, Glymph C, et al. Clinical spectrum and histopathologic features of chronic hepatitis C infection in children. J Pediatr 2007;150:168-74.
63. Rubbia-Brandt L, Leandro G, Spahr L, et al. Liver steatosis in chronic hepatitis C: a morphological sign suggesting infection with HCV genotype 3. Histopathology 2001;9:119-24.
64. Murray KF, Finn LS, Taylor SL, et al. Liver histology and alanine aminotransferase levels in children and adults with chronic hepatitis C infection. J Pediatr Gastroenterol Nutr 2005;41:634-8.
65. Guido M, Bortolotti F, Leandro G, et al. Fibrosis in chronic hepatitis C acquired in infancy: is it only a matter of time? Am J Gastroenterol 2003;98:660-3.
66. Birnbaum AH, Shneider BL, Moy L. Hepatitis C in children. N Engl J Med 2000;342:290-1.
67. Bortolotti F, Guido M, Zancan L, et al. Long-term outcome of hepatitis C in children. Letter. Hepatology 2004;5:1455.
68. Rumbo C, Fawaz RL, Emre SH, et al. Hepatitis C in children: a quaternary referral center perspective. J Pediatr Gastroenterol Nutr 2006;43:209-16.
69. Bortolotti F, Muratori L, Jara P, et al. Hepatitis C virus infection associated with liver-kidney microsomal antibody type 1 (LKM1) autoantibodies in children. J Pediatr 2003;142:185-90.
70. Adinolfi LE, Gambardella M, Andreana A, et al. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology 2001;33:1358-64.
71. Fartoux L, Chazouilleres O, Wendum D, et al. Impact of steatosis on progression of fibrosis in patients with mild hepatitis C. Hepatology 2005;41:82-7.
72. Patton HM, Patel K, Behling C, et al. The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients. J Hepatol 2004;40:484-90.
73. Giannattasio A, Spagnuolo MI, Sepe A, et al. Is HCV infection associated with liver steatosis also in children? J Hepatol 2006;45:350-4.
74. Iorio R, Giannattasio A, Sepe A, et al. Chronic hepatitis C in childhood: an 18-year experience. Clin Infect Dis 2005;41:1431-7.
75. Guido M, Bortolotti F, Jara P, et al. Liver steatosis in children with chronic hepatitis C. Am J Gastroenterol 2006;101:2611-5.
76. Micheloud D, Jensen J, Bellon JM, et al. Slow progression of human immunodeficiency virus and hepatitis C virus disease in a cohort of coinfected children. Pediatr Infect Dis J 2007;26:846-9.
77. Davison SM, Mieli-Vergani G, Sira J, et al. Perinatal hepatitis C virus infection: diagnosis and management. Ach Dis Child 2006;91:781-5.